Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nova Plasma is a private Israeli medical device company developing cold plasma-based technologies for healthcare applications. Its proprietary platform is used to create miniature cold plasma systems for dental implant surface activation, nail fungus treatment, disinfection, wound healing, and tissue regeneration. The company markets Active+, a device that activates dental implants at the point of care to improve hydrophilicity and support osseointegration, and it is also developing a handheld device for onychomycosis treatment. Nova Plasma operates internal R&D and microbiology capabilities and collaborates with larger multinational partners to co-develop products. The business sits at the intersection of medtech and applied plasma engineering rather than therapeutics-focused biotech or pharma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nova Plasma.